A search at the store earlier this year found illegal vapes, erectile dysfunction tablets, chewing tobacco and untaxed beer, ...

Cerebras Systems Inc. – a California-based artificial intelligence company is seeking to go public in the US at a valuation ...

This year's International Symposium on Liver Diseases (IISLD) 2024, held in the San Diego Convention Center, includes two key ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

Daryl Brown, who was prescribed the antidepressant Seroxat in childhood because of his Tourette’s syndrome and OCD, tells ...

We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

Biohaven has surged driven by promising data from its troriluzole trials for spinocerebellar ataxia and ongoing OCD studies.

United Kingdom equities were higher at the close on Friday, as gains in the FTSE 350 Mining, FTSE 350 Household Goods and ...

Trading Standards said Gurmej Singh was found to be selling more than 200 illegal vapes, Indian erectile dysfunction tablets, ...

Global equity markets climbed higher at the end of the week as the FTSE was aided by the UK economy’s return to growth. Fresh ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.